The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke
RecruitingNCT04789616Phase: PHASE2Started 2022-09-15
Summary
The CAMAROS trial is a randomized controlled phase II trial analyzing the effect of coupling a C-C chemokine receptor 5 (CCR5) antagonist, Maraviroc (Celsentri), and exercise to improve both upper and
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
University of Calgary & Foothills Medical CentreCalgary, Alberta, Canada
University of British Columbia & GF Strong Rehabilitation CeVancouver, British Columbia, Canada
Dalhousie UniversityHalifax, Nova Scotia, Canada
Parkwood InstituteLondon, Ontario, Canada
Sunnybrook Health Sciences CentreToronto, Ontario, Canada
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT04789616